Hanmi Pharm. Co., Ltd. 128940.KS · Stock Open Hanmi Pharm. Co., Ltd. in new tab
Hanmi Pharm. Co., Ltd. Analysis (128940.KS)
Is Hanmi Pharm. Co., Ltd. a good investment? Hanmi Pharm. Co., Ltd. (128940.KS) is currently trading at 539000.00 KRW. Market analysts have a consensus price target of 572666.70 KRW. This suggests a potential upside from current levels.
Earnings Schedule: Hanmi Pharm. Co., Ltd. is expected to release its next earnings report on Aug. 19, 2026.
For income investors, Hanmi Pharm. Co., Ltd. pays a dividend yield of 0.41%. With a payout ratio of 15%, the dividend appears sustainable.
Investor FAQ
Does Hanmi Pharm. Co., Ltd. pay a dividend?
Yes, it pays an annual dividend of 2000.00 KRW (0.41% yield).
What asset class is Hanmi Pharm. Co., Ltd.?
Hanmi Pharm. Co., Ltd. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 19, 2026.
Company Profile
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
| Year | Total Dividends |
|---|---|
| ▸2027 |
2,050.20 KRW
|
| April 12, 2027 (estimated) | 2,050.2000 |
| ▸2026 |
2,250.00 KRW
|
| Aug. 14, 2026 (estimated) | 250.0000 |
| April 17, 2026 | 2,000.0000 |
| ▸2025 |
1,250.00 KRW
|
| Aug. 14, 2025 | 250.0000 |
| April 14, 2025 | 1,000.0000 |
| ▸2024 |
750.00 KRW
|
| Aug. 14, 2024 | 250.0000 |
| April 12, 2024 | 500.0000 |
| ▸2023 |
490.20 KRW
|
| April 5, 2023 | 490.1961 |
| ▸2022 |
480.58 KRW
|
| April 5, 2022 | 480.5844 |
| ▸2021 |
471.16 KRW
|
| April 2, 2021 | 471.1612 |
| ▸2020 |
452.87 KRW
|
| April 2, 2020 | 452.8654 |
| ▸2019 |
452.87 KRW
|
| April 12, 2019 | 452.8654 |
| ▸2018 |
443.99 KRW
|
| April 13, 2018 | 443.9857 |
| ▸2015 |
1,595.31 KRW
|
| Dec. 29, 2015 | 1,595.3088 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Hanmi Pharm. Co., Ltd. | Apr 17, 2026 | Paid | 2000.0 KRW |
| Hanmi Pharm. Co., Ltd. | Aug 14, 2025 | Paid | 250.0 KRW |
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 29, 2010 | 1.050000 |
| Dec. 28, 2011 | 1.050000 |
| Dec. 27, 2012 | 1.050000 |
| Feb. 10, 2014 | 1.050000 |
| Dec. 29, 2014 | 1.050000 |
| Dec. 29, 2015 | 1.020000 |
| Feb. 15, 2017 | 1.070000 |
| Dec. 27, 2017 | 1.020000 |
| Dec. 27, 2018 | 1.020000 |
| Dec. 27, 2019 | 1.020000 |
| Dec. 29, 2020 | 1.020000 |
| Dec. 29, 2021 | 1.020000 |
| Dec. 28, 2022 | 1.020000 |
| Dec. 27, 2023 | 1.020000 |
| Dec. 16, 2013 | 1.020000 |
Community Discussion